Positional identity of a cell is a critical feature of all multicellular organisms, the essential characteristics of which extend across the whole evolutionary spectrum. Although the pioneering studies were initially performed in Drosophila melanogaster and Caenorhabditis elegans, it is now clear that the lessons learned in these model organisms are highly relevant to tissue homeostasis in humans. Thus, loss of control of cell polarity is a fundamental feature in the development of many human tumours, aiding uncontrolled cell division and proliferation, and ultimately contributing to cell invasion and metastasis.
Cell polarity is the property of a cell to display an asymmetry of its cellular constituents. There are many variations in how cellular polarization has been used by organisms to confer specific functions and developmental potential. These include the apical-basal polarity of cells so essential to the function of epithelial structures, the anterior-posterior polarity of migrating cells, the propagation of asymmetry through cell division central to stem cell function, and varieties of specialized polarity such as those seen in neuronal axon specification and lymphocyte synapse formation. In the context of a whole tissue, the individual orientation of cells can also give rise to higher orders of organization, such as planar cell polarity in cell sheets. Such organization, for example, is needed in convergent extension movements in embryogenesis or the exquisite structure of the mammalian cochlea inner ear cells for proper signal propagation.
In the same way that other fundamental processes, such as the control of cell cycle and apoptosis are disrupted during tumourigenesis, it is not surprising to find that the loss of cell polarity and disorganization of tissue architecture are key features of most human tumours. The key question, however, is whether the disorganization of tumours is a driver of cancer development or merely a manifestation of unrestricted growth and survival of tumour cells. It is clear that communication with the microenvironment plays a critical role in the evolution of tumours. In this context, cell polarity is fundamental for the structural integrity of complex tissues, and also for the correct partitioning of cell signalling components at both cellular and whole tissue levels. Therefore understanding how cell polarity is established and maintained, and how its disruption can promote tumourigenesis is an extremely important emerging field that has until recently received little attention. The aim of this special review issue is to highlight our current understanding of the role of polarity in the development of human malignancies.
Cell polarity is established through the directed transport of cellular constituents by the cytoskeleton and the vesicle trafficking machinery to various cellular domains (Tanos and Rodriguez-Boulan, this issue). In epithelial cells, the establishment of junctions is essential for the initiation and reinforcement of polarity, and longterm for the maintenance of structural domains of the cell (Tsukita et al., this issue; Jeanes et al., this issue). How these processes are orchestrated has only recently been determined by analysis of model organisms such as C. elegans and D. melanogaster. A number of key protein complexes appear to be required to determine cellular domains, and these can work together or in opposition to set domain boundaries. They include the Par, Scribble, Crumbs and Pins complexes, and examination of their mammalian orthologues indicates that these act in a very similar manner to regulate polarity (Humbert et al., this issue; Aranda et al., this issue). Indeed, many if not most, of the proteins in these complexes represent signalling adaptors whose major function is to spatially regulate various signalling pathways. Interestingly, these same complexes appear to be used over and over to regulate a wide variety of asymmetries in multiple cell lineages (Hawkins and Russell, this issue) indicating that these are core components of the cell polarity machinery.
What do we know about the role of cell polarity in cancer? Loss of cell polarity has long been recognized by pathologists as one of the earliest hallmarks of cancer development. However, if disruption of cell polarity drives tumourigenesis then one might expect to find functional inactivation of the genes that regulate polarity (that is, the polarity complexes, the junctional proteins and/or vesicle and cytoskeletal components) in human tumours. Although classic mutational inactivation, as seen with established tumour suppressors such as p53, is rarely found in the core components of the cell polarity regulatory machinery, other types of inactivation at the level of gene or epigenetic regulation (Moreno So how does loss of polarity affect cancer? In general, cell polarity and tissue organization has long been thought to have a strong tumour suppressive role. Loss of apico-basal polarity can lead to 'mixing' of membrane domains and ectopic activation of signalling pathways and aberrant signalling between cells within a tissue (Aranda et al., this issue; Tanos and RodriguezBoulan, this issue). Loss of apico-basal polarity is also central to the process of epithelial-to-mesenchymal transition, that is, increasingly being implicated as an important process in the development of invasive (and metastatic) tumours (Moreno-Bueno et al., this issue). Loss of polarity in the context of migration control is also a critical step in the process of tumour invasion and metastasis (Etienne-Manneville, this issue). A controversial, but intensively studied area in cancer research currently is the field of cancer stem cells (or cancer initiating cells). Central to this idea is that the control of asymmetric division required to balance the generation of progenitors versus stem cell self-renewal may be defective in tumours (Januschke and Gonzalez, this issue). Although less studied, it is also likely that the signals regulating organ size and organization, that is, higher order polarity, will also be deregulated in cancer (Lopez et al., this issue) . In this instance, cancer would represent a failed attempt at organogenesis due to lack of an overarching tissue structure. Lastly, it is important to note that since polarity proteins appear to act as signalling adaptors that localize signalling, the main effect of inactivation of these complexes could be to give rise to aberrant oncogenic signalling rather than loss of polarity per se (Aranda et al., this issue).
It is clear from the reviews collected here that the future of the field will rely on a number of key studies. First, the demonstration that the levels or functional status of polarity regulators in tumours correlate with disease outcome. Second, that the alterations observed in human tumours are causative. Mouse and other animal models of cancer will be essential to definitely determine this. Studies of proteins such as E-cadherin and LKB1 in human cancer and mouse models provide a solid foundation to expand on and to begin relating effects directly to polarity (Jeanes et al., this issue; Hezel and Bardeesy, this issue). The fact that the minimalist oncogenic viruses have troubled themselves to target this cellular process (Javier, this issue; Thomas et al., this issue) is also a clear validation of the importance of cell polarity in tumourigenesis. The study of the mechanism of action of these tumour viruses will, as it has in the past with the study of cell cycle and apoptosis in cancer, provide critical tools to understand the role of cell polarity in the development of human cancers.
The cumulative weight of evidence for a role for polarity in tumour development has now made the study of cell polarity and cancer a burgeoning field. This collection of 14 reviews, in a special review issue of Oncogene, provides a judicious and timely insight into the current evidence implicating cell polarity and its regulators in the development of cancer.
